Brought to you by www.DealSearchOnline.com
Week Ending November 21, 2014:
Recent Health Care M&A Deals
License to Optogenetics portfolio
Vivex Biomedical, Inc.
Assets and agreements
Lee Equity Partners
LDM Group, LLC
The Allergan/Actavis Deal Is Just a Drop in the Bucket
Allergan, Inc. (NYSE: AGN) spent much of the year battling a hostile takeover by Valeant Pharmaceuticals International, Inc. (NYSE: VRX), which offered $54 billion in cash and stock and aimed to take $2.7 billion in costs out of the Botox maker’s operations after the deal closed. Allergan’s board didn’t like the price or the idea, and found Actavis plc (NYSE: ACT), and made a deal for $66 billion. “Everyone knows that,” you say? Well, did you know that that $66 billion price tag, which makes it the year’s biggest health care deal so far, is just 18% of the total health care M&A spending in 2014? Yes, you heard us: Just 18% of the $361 billion announced in 2014. So far.
The Top 10 Years for Hospital M&A, by Deal Volume
True mergers and acquisitions are hard to come by these days, as hospitals and health systems team up through affiliations, collaborations, joint ventures and partnerships. So far this year, we’ve logged just 48 hospital transactions, which puts us way behind 2013’s 84 deals. We went back to our DealSearchOnline.com database to find out which years were the busiest for hospital M&A activity. Those of you who’ve been in the business for a while won’t be surprised to see that the 1990s were the heyday for Hospital M&A. We’ll discuss this in greater length in the December issue of Health Care M&A News. See you there.
10 Biggest Years for Hospital M&A, by Deal Volume
Source: The Health Care M&A Information Source, November 2014
Fresenius’ New Hospitalist Company Makes Its First Acquisition
Sound Physicians, which was acquired by Fresenius Medical Care (NYSE: FMS) in June 2014 for $600 million, has made its first acquisition, Brentwood, Tennessee-based Cogent Healthcare, a physician medical group with more than 650 providers who deliver hospitalist services to more than 80 hospitals around the United States. They join Sound Physicians’ more than 1,100 hospitalists and acute-care physicians at more than 100 hospitals.
Precision Therapeutics Completes $60 Million Financing Round
Precision Therapeutics, Inc. has changed its name to Helomics Corporation, a privately held comprehensive personalized healthcare company that develops next-generation diagnostics for the oncology field. Its leading product is ChemoFx® Chemoresponse Marker, which helps physicians select effective treatments for women with gynecologic cancer. Helomics also announced the culmination of recapitalization, to the tune of $60 million from HealthCare Royalty Partners………..Click here for a free trial to The Health Care M&A Information Source and download the current issue today.
Around the Web in Health Care M&A…Click here to see more
Webcast Calendar…Click here to see more
Upcoming Investor Conferences…Click here to see more
Previous Issues of Health Care Deal News…Click here to see more